315 related articles for article (PubMed ID: 29719792)
1. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
4. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies.
Biondini D; Balestro E; Sverzellati N; Cocconcelli E; Bernardinello N; Ryerson CJ; Spagnolo P
Expert Rev Respir Med; 2020 Apr; 14(4):405-414. PubMed ID: 31994940
[No Abstract] [Full Text] [Related]
6. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T
Eurasian J Med; 2017 Oct; 49(3):204-206. PubMed ID: 29123445
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A historically controlled study.
Sakamoto S; Shimizu H; Isshiki T; Sugino K; Kurosaki A; Homma S
Respir Investig; 2018 Mar; 56(2):136-143. PubMed ID: 29548651
[TBL] [Abstract][Full Text] [Related]
8. Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Kishaba T
Medicina (Kaunas); 2019 Mar; 55(3):. PubMed ID: 30884853
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial.
Hayakawa S; Matsuzawa Y; Irie T; Rikitake H; Okada N; Suzuki Y
Multidiscip Respir Med; 2016; 11():38. PubMed ID: 27826444
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.
Yamazoe M; Tomioka H
BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study.
Isshiki T; Sakamoto S; Kinoshita A; Sugino K; Kurosaki A; Homma S
Respiration; 2015; 89(3):201-7. PubMed ID: 25659984
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
Wang B; Li T
Exp Ther Med; 2020 Jul; 20(1):351-358. PubMed ID: 32537001
[TBL] [Abstract][Full Text] [Related]
13. Acute Exacerbation in Interstitial Lung Disease.
Leuschner G; Behr J
Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome?
Marchioni A; Tonelli R; Ball L; Fantini R; Castaniere I; Cerri S; Luppi F; Malerba M; Pelosi P; Clini E
Crit Care; 2018 Mar; 22(1):80. PubMed ID: 29566734
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
Isshiki T; Sakamoto S; Homma S
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137593
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbations of interstitial lung disease: lessons from idiopathic pulmonary fibrosis.
Spagnolo P; Wuyts W
Curr Opin Pulm Med; 2017 Sep; 23(5):411-417. PubMed ID: 28582317
[TBL] [Abstract][Full Text] [Related]
18. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
19. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
20. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
